Michael I. Lerman

Active 1983–2016

66
Papers
20,782
Citations
65
h-index
65
i10-index

Citations

Citations per year for Michael I. Lerman1971: 1 citations1984: 8 citations1985: 6 citations1986: 4 citations1987: 24 citations1988: 43 citations1989: 41 citations1990: 42 citations1991: 44 citations1992: 56 citations1993: 61 citations1994: 94 citations1995: 151 citations1996: 162 citations1997: 213 citations1998: 203 citations1999: 210 citations2000: 205 citations2001: 257 citations2002: 353 citations2003: 367 citations2004: 314 citations2005: 283 citations2006: 205 citations2007: 230 citations2008: 180 citations2009: 181 citations2010: 176 citations2011: 140 citations2012: 167 citations2013: 134 citations2014: 122 citations2015: 88 citations2016: 107 citations2017: 80 citations2018: 81 citations2019: 282 citations2020: 232 citations2021: 228 citations2022: 159 citations2023: 106 citations2024: 154 citations2025: 60 citations1972–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,372 citing papers, 37.8% of this breakdownUnited Kingdom: 480 citing papers, 7.6% of this breakdownGermany: 338 citing papers, 5.4% of this breakdownChina: 333 citing papers, 5.3% of this breakdownJapan: 332 citing papers, 5.3% of this breakdownItaly: 247 citing papers, 3.9% of this breakdownCanada: 230 citing papers, 3.7% of this breakdownFrance: 229 citing papers, 3.6% of this breakdownNetherlands: 150 citing papers, 2.4% of this breakdownSwitzerland: 112 citing papers, 1.8% of this breakdownAustralia: 111 citing papers, 1.8% of this breakdownSweden: 101 citing papers, 1.6% of this breakdown
0%37.8%Other 19.8%

Fields

  • Biochemistry, Genetics and Molecular Biology50.6%
  • Medicine39%
  • Neuroscience4.1%
  • Immunology and Microbiology3%
  • Agricultural and Biological Sciences1.3%
  • Veterinary0.6%
  • Other1.4%

Topics

  • Cancer, Hypoxia, and Metabolism5.9%
  • Epigenetics and DNA Methylation5.8%
  • Renal cell carcinoma treatment4.8%
  • Alzheimer's disease research and treatments3.3%
  • RNA modifications and cancer3%
  • Renal and related cancers2.9%
  • Other74.3%

Coauthors

All papers

Open in search
  1. Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , W. Marston Linehan, Berton Zbar, Michael I. Lerman - Science 1993 cited by 3,015

  2. Mutations of the VHL tumour suppressor gene in renal carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 1994 cited by 1,741

  3. Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer

    Authors: , , , , , , , , , , - Cancer Research 2016 cited by 123

  4. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Cell 2002 cited by 937

  5. Expression of Hypoxia-Inducible Cell-Surface Transmembrane Carbonic Anhydrases in Human Cancer

    Authors: , , , , , , , , , , , , , , - American Journal Of Pathology 2001 cited by 683

  6. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1994 cited by 1,542

  7. Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2008 cited by 186

  8. Characterization and Chromosomal Localization of a cDNA Encoding Brain Amyloid of Alzheimer's Disease

    Authors: , , , , - Science 1987 cited by 1,328

  9. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers

    Authors: , , - Oncogene 2002 cited by 386

  10. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?

    Authors: , , , , - Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2009 cited by 248

  11. Functional Properties of a New Voltage-dependent Calcium Channel α2δ Auxiliary Subunit Gene (CACNA2D2)

    Authors: , , , , , , , , , , , - Journal of Biological Chemistry 2000 cited by 192

  12. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.

    Authors: , , , , , , , , , , , , , - 2000 cited by 406

  13. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 cited by 397

  14. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 329

  15. Expression of transmembrane carbonic anhydrases, CAIX and CAXII, in human development

    Authors: , , - BMC Developmental Biology 2009 cited by 88

  16. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.

    Authors: , , , , , , , , , , , , , , - 2003 cited by 658

  17. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.

    Authors: , - 2000 cited by 540

  18. Hereditary Papillary Renal Cell Carcinoma

    Authors: , , , , , , , , - The Journal of Urology 1994 cited by 316

  19. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns.

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1996 cited by 236

  20. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect

    Authors: , , , , , , , , , - Human Genetics 1995 cited by 181

  21. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo.

    Authors: , , , , , , , , , , , , - 2002 cited by 177

  22. Molecular and cellular characterization of human renal cell carcinoma cell lines.

    Authors: , , , , , , , - 1992 cited by 110

  23. Cerebellar Ataxia, Seizures, Premature Death, and Cardiac Abnormalities in Mice with Targeted Disruption of the Cacna2d2 Gene

    Authors: , , , , , , , , , , , , , , , , - American Journal Of Pathology 2004 cited by 108

  24. Functional Characterization of the Candidate Tumor Suppressor Gene NPRL2 / G21 Located in 3p21.3C

    Authors: , , , , , , , , , , , , , - Cancer Research 2004 cited by 83